logo

FDA Calendar

Share
Company Name Sarepta Therapeutics
Drug Name Casimersen (NDA)
Event Name FDA decision on Casimersen for DMD amenable to Exon 45 skipping
Event Date 02/25/2021
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar